BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 35692329)

  • 1. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.
    Qiu H; Cao S; Xu R
    Cancer Commun (Lond); 2021 Oct; 41(10):1037-1048. PubMed ID: 34288593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National burden of cancer in Italy, 1990-2017: a systematic analysis for the global burden of disease study 2017.
    Bosetti C; Traini E; Alam T; Allen CA; Carreras G; Compton K; Fitzmaurice C; Force LM; Gallus S; Gorini G; Harvey JD; Kocarnik JM; La Vecchia C; Lugo A; Naghavi M; Pennini A; Piccinelli C; Ronfani L; Xu R; Monasta L
    Sci Rep; 2020 Dec; 10(1):22099. PubMed ID: 33328623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of female infertility in China from 1990 to 2019: a temporal trend analysis and forecasting, and comparison with the global level.
    Yu J; Fu Y; Zeng L; Xie P; Li L; Zheng Y
    Sex Health; 2023 Dec; 20(6):577-584. PubMed ID: 37967574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
    He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
    Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer prevention and control: alarming challenges in China.
    Bode AM; Dong Z; Wang H
    Natl Sci Rev; 2016 Mar; 3(1):117-127. PubMed ID: 27308066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019.
    Santos JV; Padron-Monedero A; Bikbov B; Grad DA; Plass D; Mechili EA; Gazzelloni F; Fischer F; Sulo G; Ngwa CH; Noguer-Zambrano I; Peñalvo JL; Haagsma JA; Kissimova-Skarbek K; Monasta L; Ghith N; Sarmiento-Suarez R; Hrzic R; Haneef R; O'Caoimh R; Cuschieri S; Mondello S; Kabir Z; ; Freitas A; Devleesschauwer B
    BMC Public Health; 2024 May; 24(1):1374. PubMed ID: 38778362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe.
    Gao TY; Tao YT; Li HY; Liu X; Ma YT; Li HJ; Xian-Yu CY; Deng NJ; Leng WD; Luo J; Zhang C
    J Glob Health; 2024 Jan; 14():04014. PubMed ID: 38271210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years.
    Niu D; Zhao Y; Wang J; Ye E; Huang J; Liu J; Huang X; Yue S; Hou X; Wu J
    Ann Hematol; 2023 Sep; 102(9):2375-2386. PubMed ID: 37468671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the disease burden of breast cancer along with attributable risk factors in China from 1990 to 2019 and its projections: An analysis of the global burden of disease study 2019.
    Li J; Chen C; Nie J; Wang L; Zhang Z; Li Y
    Cancer Med; 2023 Jan; 12(2):1888-1902. PubMed ID: 35785526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thirty-year changes in disability adjusted life years for colorectal cancer in China: a screening perspective analysis].
    Li YJ; Cao MD; Wang X; Lei L; Peng J; Shi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1381-1387. PubMed ID: 36117343
    [No Abstract]   [Full Text] [Related]  

  • 11. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies.
    Charlson FJ; Baxter AJ; Cheng HG; Shidhaye R; Whiteford HA
    Lancet; 2016 Jul; 388(10042):376-389. PubMed ID: 27209143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol Use and Cancer in the European Union.
    Rehm J; Shield KD
    Eur Addict Res; 2021; 27(1):1-8. PubMed ID: 32417845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA.
    Yang X; Chen H; Sang S; Chen H; Li L; Yang X
    Front Public Health; 2022; 10():862165. PubMed ID: 35692329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea.
    Yang S; Lin S; Li N; Deng Y; Wang M; Xiang D; Xiang G; Wang S; Ye X; Zheng Y; Yao J; Zhai Z; Wu Y; Hu J; Kang H; Dai Z
    J Hematol Oncol; 2020 Nov; 13(1):146. PubMed ID: 33138852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the disease burden attributable to PM
    Du J; Yang J; Wang L; Wu X; Cao W; Sun S
    Ecotoxicol Environ Saf; 2021 Feb; 209():111856. PubMed ID: 33412383
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.